Prandin (Gemini Laboratories, LLC)
Welcome to the PulseAid listing for the Prandin drug offered from Gemini Laboratories, LLC. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gemini Laboratories, LLC |
NON-PROPRIETARY NAME: | Repaglinide |
SUBSTANCE NAME: | REPAGLINIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | PILL |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-02 |
END MARKETING DATE: | 0000-00-00 |
Prandin HUMAN PRESCRIPTION DRUG Details:
Item Description | Prandin from Gemini Laboratories, LLC |
LABELER NAME: | Gemini Laboratories, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mg) |
START MARKETING DATE: | 2017-02-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60846-882_4d8e98dd-7660-6afb-e054-00144ff88e88 |
PRODUCT NDC: | 60846-882 |
APPLICATION NUMBER: | ANDA077571 |
Other REPAGLINIDE Pharmaceutical Manufacturers / Labelers: